Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evogene (EVGN) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Evogene (EVGN) over the last 15 years, with Q3 2025 value amounting to $379000.0.

  • Evogene's Receivables - Net fell 7616.35% to $379000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $379000.0, marking a year-over-year decrease of 7616.35%. This contributed to the annual value of $1.1 million for FY2024, which is 20560.22% up from last year.
  • Latest data reveals that Evogene reported Receivables - Net of $379000.0 as of Q3 2025, which was down 7616.35% from $1.1 million recorded in Q2 2025.
  • Over the past 5 years, Evogene's Receivables - Net peaked at $2.6 million during Q1 2025, and registered a low of $111000.0 during Q2 2022.
  • In the last 5 years, Evogene's Receivables - Net had a median value of $357000.0 in 2023 and averaged $620578.9.
  • Within the past 5 years, the most significant YoY rise in Evogene's Receivables - Net was 38979.59% (2025), while the steepest drop was 7616.35% (2025).
  • Evogene's Receivables - Net (Quarter) stood at $281000.0 in 2021, then increased by 23.84% to $348000.0 in 2022, then rose by 2.59% to $357000.0 in 2023, then surged by 205.6% to $1.1 million in 2024, then crashed by 65.26% to $379000.0 in 2025.
  • Its Receivables - Net was $379000.0 in Q3 2025, compared to $1.1 million in Q2 2025 and $2.6 million in Q1 2025.